Related Experiment Video

Updated: Aug 14, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Elevated troponin level is not synonymous with myocardial infarction

Nitin Mahajan1, Yatin Mehta, Malcolm Rose

  • 1Department of Medicine, Maimonides Medical Center, Brooklyn, NY 11219, USA. nmahajan@maimonidesmed.org

International Journal of Cardiology
|November 18, 2005
PubMed

Insights

Elevated cardiac troponin I (cTnI) in patients with normal coronary arteries can stem from various conditions beyond heart attacks. Understanding these causes is crucial for accurate diagnosis and treatment.

Area of Science:

  • Cardiology
  • Biomarkers
  • Diagnostic Medicine

Background:

  • Elevated cardiac troponin I (cTnI) without coronary lesions occurs in 10-15% of patients with suspected coronary artery disease.
  • This phenomenon necessitates investigating the underlying causes of elevated cTnI in patients with normal coronary arteries.

Purpose of the Study:

  • To determine the etiologies of elevated cardiac troponin I (cTnI) in patients presenting with normal coronary arteries on angiography.
  • To differentiate causes of elevated cTnI from acute myocardial infarction in this patient group.

Main Methods:

  • Retrospective analysis of 17,950 catheterization records (Jan 2000-Jun 2004).
  • Identified 1551 patients (8.6%) with normal coronary arteries.
  • Focused on 144 patients with elevated cTnI, comparing them to age- and gender-matched myocardial infarction patients.

Main Results:

  • Patients with elevated cTnI and normal coronary arteries showed fewer atherosclerotic risk factors and higher left ventricular ejection fractions.
  • Identified causes included tachycardia, myocarditis, pericarditis, aortic stenosis, sepsis, heart failure, pulmonary embolism, and coronary spasm.

Conclusions:

  • Elevated cardiac troponin I (cTnI) can indicate myonecrosis from various conditions, not solely acute myocardial infarction.
  • Acute myocardial infarction is a clinical diagnosis; laboratory results like cTnI are supportive, not definitive.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...